Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer

Thoracic and Cardiovascular Surgeon

Volumn 60, Issue 2, 2012, Pages 105-110

  Tamura, Masaya ^a   Oda, Makoto ^a   Matsumoto, Isao ^a   Waseda, Ryuichi ^a   Watanabe, Go ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

false positive; lung cancer diagnosis (includes staging imaging fiducials); lung cancer treatment (surgery medical); lymph node staging; non small cell lung cancer; PET CT; positron emission tomography, PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVIEW; STANDARDIZED UPTAKE VALUE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 84858427447     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0031-1280068     Document Type: Review

References (21)

1. Cerfolio RJ, Buddhiwardhan O, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET/CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg: 2004; 78 1017 1023 (Pubitemid 39164825)
2. Antoch G, Stattaus J, Nemat AT., et al. Non-small cell lung cancer: dual modality PET/CT in preoperative staging. Radiology: 2003; 229 526 533 (Pubitemid 37310842)
3. Lardinois D, Weder W, Hany TF., et al. Staging of non-small cell lung cancer with integrated positron emission tomography and computed tomography. N Engl J Med: 2003; 348 2500 2507 (Pubitemid 36706537)
4. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg: 1996; 111 642 648 (Pubitemid 26087729)
5. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology: 2004; 231 305 332 (Pubitemid 38552885)
6. Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small lung cancer patients with enlarged lymph nodes: analysis of 1145 lymph nodes. Lung Cancer: 2008; 60 62 68 (Pubitemid 351434459)
7. Al-Sarraf N, Aziz R, Doddakula K., et al. Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography. Interact Cardiovasc Thorac Surg: 2007; 6 350 353 (Pubitemid 46849702)
8. 18F-FDG PET/CT in a tuberculosis-endemic country. Diagnostic efficacy in 674 patients. Cancer: 2007; 109 1068 1077 (Pubitemid 46435384)
9. Fischer M, Lassen U, Mortensen J., et al. Preoperative staging of lung cancer with combined PET-CT. N Eng J Med: 2009; 36 32 39
10. Nabi HA, Zubeldia JM. Clinical applications of F18-FDG in oncology. J Nucl Med Technol: 2002; 30 3 9
11. Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Interact Cardiovasc Thorac Surg: 2010; 10 200 203
12. Byant AS, Cerfolio RJ, Klemm KM, Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg: 2006; 82 417 423 (Pubitemid 44080009)
13. Graeter TP, Hellwig D, Hoffman K, Ukena D, Kirsch CM, Schaefers HJ. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg: 2003; 75 231 236 (Pubitemid 36099053)
14. Hellwig D, Graeter TP, Ukena D., et al. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med: 2007; 48 1761 1766 (Pubitemid 350099319)
15. Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax: 2007; 62 696 701 (Pubitemid 47235013)
16. Nael AS, Rashid A, Kathy G., et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiovasc Surg: 2008; 33 104 109
17. Abel GC, Samuel G, Noemi R., et al. Incidence of occult mediastinal node involvement in cN0 non-small cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan. Eur J Cardiovasc Surg: 2010; 37 1168 1174
18. Perigaud C, Bridji B, Roussel JC., et al. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small cell lung cancer. Eur J Cardiothorac Surg: 2009; 36 731 736
19. Uesaka D, Demura Y, Ishizaki T., et al. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer. J Nucl Med: 2008; 49 1606 1612
20. Chung JH, Cho KJ, Lee SS., et al. Overexpression of Glut 1 in lymphoid follicles correlates with false-positive 18F-FDG-PET results in lung cancer staging. J Nucl Med: 2004; 45 999 1003
21. Demura Y, Tsuchida T, Ishizaki T., et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med: 2003; 44 540 548 (Pubitemid 39663420)